China International Medicinal Equipment Fair (CMEF)
view counter

Category: Stem CellsSyndicate content

Aastrom Biosciences winds up treatment stage of Phase 2 clinical trial

March 9, 2010 by MedCity News

Aastrom Biosciences Inc. finished the treatment stage of its Phase 2 clinical trial examining its stem cell-based treatment for dilated cardiomyopathy, a severe form of congestive heart failure.

MedCity News logo

By Brandon Glenn

Aastrom Biosciences Inc. (NSDQ:ASTMD) finished treating patients in a Phase 2 clinical trial of its cardiac-repair stem cells.

The milestone clears the way for Aastrom to report six-month interim results of the trial later this year, according to a press release.

In the trial, Aastrom treated 40 patients suffering from dilated cardiomyopathy, a severe form of congestive heart failure in which the heart becomes weakened and enlarged and cannot pump blood efficiently.

Biocell Center inks stem cell deal with Caritas Christi hospitals

March 8, 2010 by MassDevice staff

Biocell Center Corp. and the Caritas Christi Health Care network of hospitals launch a program to preserve stem cells from amniotic fluid.

Biocell logo

Biocell Center Corp. and Caritas Christi Health Care inked a deal to start a cryopreservation service for amniotic fluid stem cells.

The Italian biotech firm, which has its U.S. headquarters in Medford, Mass., and New England's largest community hospital network will use Biocell's method of preserving stem cells obtained during routine second-trimester amniocentesis procedures. The mesenchymal stem cells can be stored for decades and are believed to hold the key to treating or even eventually curing a raft of diseases. Parents can opt to preserve the cells for use in the event of future illness for themselves or their children.

Aastrom Biosciences back in NASDAQ's good graces

March 5, 2010 by MassDevice staff

Stem cell firm Aastrom Biosciences regained the good graces of the NASDAQ stock exchange as its per share price climbs above the exchange's $1 minimum.

By Brandon Glenn

MedCity News logo

ANN ARBOR, Mich. – Aastrom Biosciences (NSDQ:ASTMD), once in danger of being de-listed from the NASDAQ exchange, regained compliance with the exchange’s $1 minimum-share-price requirement.

Harvest Technologies completes clinical trial enrollment

November 9, 2009 by MassDevice staff

Forty-eight patients in the U.S. and India will participate in a trial of the Plymouth, Mass.-based company's technique to use concentrated autologous bone marrow cells to treat patients with non-reconstructable critical limb ischemia.

Harvest Technologies completes clinical trial enrollment

Harvest Technologies Corp. completed enrollment in a clinical trial of its technique to use concentrated autologous bone marrow cells to treat patients with non-reconstructable critical limb ischemia.

European biotech firm Biocell opens U.S. HQ in Medford, Mass.

October 22, 2009 by MassDevice staff

The company, which pioneered a method of preserving amniotic stem cells, opens a tissue bank and research operation just north of Boston.

European biotech firm Biocell opens U.S. HQ in Medford, Mass.

Biocell Center Corp., the European biotech firm that pioneered a method of preserving amniotic stem cells, opened its U.S. headquarters in Medford, Mass.

Biocell CEO Kate Torchilin said the company can preserve a portion of the sample taken during amniocentesis on pregnant women, which contains stem cells that can be used to treat illness or regenerate tissue.

Harvest Technologies wins FDA approval for clinical trial

October 22, 2009 by MassDevice staff

The Plymouth, Mass.-based firm got a green light from the Food & Drug Administration to begin a trial of its technique to use stem cells during coronary artery bypass surgeries.

Harvest Technologies wins FDA approval for clinical trial

Harvest Technologies Corp. won approval from the Food & Drug Administration for a 42-patient trial of its technique to use concentrated autologous bone marrow cells to treat patients undergoing coronary artery bypass grafts.

The FDA's investigational device exemption allows the Plymouth, Mass.-based firm to study whether its BMAC system can help re-grow dead or damaged heart tissue. The two phase feasibility trial will see a one patient group injected with the concentrated stem cells after CABG surgery and a control group treated with CABG alone.

Sentien Biotechnologies

26 Inman St
Cambridge
MA
02142
United States
(617) 314-0713
Product(s): 
Develops stem cell-laden devices for acute organ failure
Employees: 
3
Established: 
2008
browse jobs and career opportunities in the medical devices industry
view counter
Free Literature and Charts from Emergo Group
view counter

Preferred Vendors

Publishing, Software / IT, Consulting

Cine-Med Inc.
Produces medical films and publishes continuing education. materials for medical device companies

Original Equipment Manufacturer

Admet
Static and Dynamic testing systems for materials, components, and devices. Systems range from 50 grams to 600kN of force capacity in tension, compression, torsion, and more.
Provides grips, fixtures, heating and cooling systems, and fluid baths.

Reimbursement, Salesforce Development and Training, Reimbursement

Medical Education Training Associates LLC (META)
Provides a suite of consulting services for medical device companies
Reimbursement Planning, Health Policy Training
Salesforce development and Management training

Consulting, Regulatory

Emergo Group, Inc.
Regulatory charts and consulting

Communications / PR, Marketing

Seidler Bernstein
Provides marketing and PR services

Machining, Prototype Manufacturing, Design / Engineering

Roush Life Sciences
Provides design and engineering, rapid prototyping, tooling, engineering and manufacturing services for life science companies
A Division of Roush Enterprises

Plastics / Molded Products, Other

The massPLASTICS Medical Device Connection is your portal to more than 35 innovative plastics companies
view counter
16th MDMA Annual Meeting - May 24-26, 2010 - Register Today
view counter
Instron manufactures tensile, compression, fatigue, impact and hardness testing machines, testing a variety of  materials and ra
view counter
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp